Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Macrolides: pharmacokinetics and pharmacodynamics.

F Van Bambeke¹, P M Tulkens

¹Unité de Pharmacologie Cellulaire et Moléculaire, Université catholique de Louvain, UCL 73.70, Avenue E. Mounier 73, B-1200 Brussels, Belgium.

International Journal of Antimicrobial Agents

|September 28, 2001

Summary

Understanding antibiotic pharmacokinetics and pharmacodynamics (PK/PD) is key to effective treatment. Optimizing PK/PD parameters like Cmax/MIC, AUC/MIC, and T>MIC maximizes antibiotic efficacy and minimizes resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term intensive care unit outbreak of carbapenemase-producing organisms associated with contaminated sink drains.

The Journal of hospital infection·2024

Same author

Reply to: 'Clinical efficacy and safety of cefiderocol in the treatment of acute bacterial infections: a systematic review and meta-analysis of randomised controlled trials'.

Journal of global antimicrobial resistance·2021

Same author

Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019

Same author

Investigation of unbound colistin A and B in clinical samples using a mass spectrometry method.

International journal of antimicrobial agents·2018

Same author

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018

Same author

Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa.

The Journal of antimicrobial chemotherapy·2017

Area of Science:

Pharmacology
Microbiology
Infectious Diseases

Background:

Antibiotic efficacy is critically influenced by pharmacokinetic/pharmacodynamic (PK/PD) parameters.
Key PK/PD predictors include peak concentration to minimum inhibitory concentration ratio (Cmax/MIC), area under the concentration-time curve to MIC ratio (AUC24h/MIC), and time concentration exceeds MIC (T>MIC).

Purpose of the Study:

To elucidate the relationship between specific PK/PD parameters and the clinical efficacy of various antibiotic classes.
To provide a framework for optimizing antibiotic dosing and administration strategies for improved outcomes and resistance management.

Main Methods:

Review and synthesis of existing literature on antibiotic PK/PD relationships.
Categorization of antibiotics based on their concentration-dependent killing and post-antibiotic effects.

Related Experiment Videos

Analysis of how different PK/PD targets (Cmax/MIC, AUC24h/MIC, T>MIC) correlate with efficacy for distinct antibiotic classes.

Main Results:

Concentration-dependent antibiotics (e.g., fluoroquinolones, aminoglycosides) show efficacy linked to Cmax/MIC and AUC24h/MIC.
Antibiotics with weak concentration-dependency (e.g., beta-lactams, macrolides) rely on T>MIC for efficacy.
Antibiotics with persistent effects (e.g., tetracyclines, azithromycin) are primarily related to AUC24h/MIC.

Conclusions:

Applying PK/PD principles allows for optimized dosing and scheduling of existing and novel antibiotics.
Strategic use of PK/PD targets can maximize therapeutic efficacy.
Optimized dosing can help prevent or delay the emergence of bacterial resistance and minimize adverse effects.